Literature DB >> 7943035

Improved sizing of fragile X CCG repeats by nested polymerase chain reaction.

G Levinson1, A Maddalena, F T Palmer, G L Harton, D P Bick, P N Howard-Peebles, S H Black, J D Schulman.   

Abstract

We have developed an improved method for polymerase chain reaction (PCR)-based sizing of the CCG repeat region at the fragile X locus, FMR-1. This method is designed to optimize denaturation and replication of long repeats with high G + C content, which are otherwise refractory to amplification. The method utilizes nested PCR primers to increase sensitivity and specificity. Alkaline denaturation of the genomic template DNA, combined with addition of glycerol and deaza-dGTP, facilitates strand separation. Labeled PCR products are sized on denaturing polyacrylamide gels. For alleles in the normal-to-premutation size range, strong reproducible signals are routinely obtained from small amounts of rapidly prepared DNA. This allows precise determination of the CCG repeat number, providing data related to the expansion potential of the repetitive segment. Detection of large premutations and some full mutations is also enhanced by the improved procedure.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7943035     DOI: 10.1002/ajmg.1320510448

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  8 in total

1.  FMR1 CGG-repeat instability in single sperm and lymphocytes of fragile-X premutation males.

Authors:  S L Nolin; G E Houck; A D Gargano; H Blumstein; C S Dobkin; W T Brown
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

2.  RS46(DXS548) genotyping of reproductive cells: approaching preimplantation testing of the fragile-X syndrome.

Authors:  J C Dreesen; J P Geraedts; J C Dumoulin; J L Evers; M H Pieters
Journal:  Hum Genet       Date:  1995-09       Impact factor: 4.132

3.  FMR1 gray-zone alleles: association with Parkinson's disease in women?

Authors:  Deborah A Hall; Elizabeth Berry-Kravis; Wenting Zhang; Flora Tassone; Elaine Spector; Gary Zerbe; Paul J Hagerman; Bichun Ouyang; Maureen A Leehey
Journal:  Mov Disord       Date:  2011-05-12       Impact factor: 10.338

4.  Genetic Counseling for Fragile X Syndrome: Recommendations of the National Society of Genetic Counselors.

Authors:  N McIntosh; L W Gane; A McConkie-Rosell; R L Bennett
Journal:  J Genet Couns       Date:  2000-08       Impact factor: 2.537

5.  A PCR amplification method reveals instability of the dodecamer repeat in progressive myoclonus epilepsy (EPM1) and no correlation between the size of the repeat and age at onset.

Authors:  M D Lalioti; H S Scott; P Genton; D Grid; R Ouazzani; A M'Rabet; S Ibrahim; R Gouider; C Dravet; T Chkili; A Bottani; C Buresi; A Malafosse; S E Antonarakis
Journal:  Am J Hum Genet       Date:  1998-04       Impact factor: 11.025

6.  The fragile X premutation in carriers and its effect on mutation size in offspring.

Authors:  G S Fisch; K Snow; S N Thibodeau; M Chalifaux; J J Holden; D L Nelson; P N Howard-Peebles; A Maddalena
Journal:  Am J Hum Genet       Date:  1995-05       Impact factor: 11.025

7.  Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles.

Authors:  Sarah L Nolin; W Ted Brown; Anne Glicksman; George E Houck; Alice D Gargano; Amy Sullivan; Valérie Biancalana; Karen Bröndum-Nielsen; Helle Hjalgrim; Elke Holinski-Feder; Frank Kooy; John Longshore; James Macpherson; Jean-Louis Mandel; Gert Matthijs; Francois Rousseau; Peter Steinbach; Marja-Leena Väisänen; Harriet von Koskull; Stephanie L Sherman
Journal:  Am J Hum Genet       Date:  2003-01-14       Impact factor: 11.025

Review 8.  Trends in Molecular Diagnosis and Diversity Studies for Phytosanitary Regulated Xanthomonas.

Authors:  Vittoria Catara; Jaime Cubero; Joël F Pothier; Eran Bosis; Claude Bragard; Edyta Đermić; Maria C Holeva; Marie-Agnès Jacques; Francoise Petter; Olivier Pruvost; Isabelle Robène; David J Studholme; Fernando Tavares; Joana G Vicente; Ralf Koebnik; Joana Costa
Journal:  Microorganisms       Date:  2021-04-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.